RGEN.NASDAQRepligen CORP

Form 4: Repligen Director Margaret Pax Reports Transaction in Company Stock

Sentiment:

SEC Form 4 Filing


Director Margaret Pax reported a transaction involving Repligen Corp (RGEN) common stock on March 17, 2025.

Summary

  • On March 17, 2025, Margaret Pax, a director of Repligen Corporation (RGEN), reported a transaction involving the company's common stock.
  • Pax acquired 250 shares of common stock at a price of $150.69 per share.
  • Following the transaction, Pax directly owns 1,043 shares of Repligen Corp.
  • The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

  • The transaction may be of interest to shareholders as it provides insight into the actions of a company director.

Key Dates

DateDescription
03/17/2025Date of transaction: Margaret Pax acquired Repligen Corp stock.
03/18/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.